<DOC>
	<DOCNO>NCT00206310</DOCNO>
	<brief_summary>The purpose study investigate rosuvastatin , add top medicine prescribe subject symptomatic systolic heart failure , reduces combine endpoint cardiovascular death non-fatal myocardial infarction non-fatal stroke ( time first event )</brief_summary>
	<brief_title>Crestor Versus Placebo Subjects With Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Chronic symptomatic systolic heart failure ischaemic aetiology judge investigator , optimal therapy chronic symptomatic systolic heart failure accord investigator Acute myocardial infarction within 6 month randomization Treatment statin lipid lowering drug ; medical condition opinion investigator require treatment statin lipid lower drug</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
</DOC>